Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Operating Leases (2019 - 2026)

Bio-Techne has reported Operating Leases over the past 7 years, most recently at $77.2 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 5.43% year-over-year to $77.2 million; the TTM value through Dec 2025 reached $77.2 million, down 5.43%, while the annual FY2025 figure was $84.0 million, 4.17% down from the prior year.
  • Operating Leases for Q4 2025 was $77.2 million at Bio-Techne, down from $80.7 million in the prior quarter.
  • Over five years, Operating Leases peaked at $97.3 million in Q3 2023 and troughed at $56.3 million in Q1 2022.
  • A 5-year average of $78.2 million and a median of $80.1 million in 2025 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: decreased 15.67% in 2022 and later soared 65.52% in 2023.
  • Year by year, Operating Leases stood at $57.7 million in 2021, then soared by 35.46% to $78.2 million in 2022, then increased by 22.82% to $96.0 million in 2023, then fell by 15.01% to $81.6 million in 2024, then fell by 5.43% to $77.2 million in 2025.
  • Business Quant data shows Operating Leases for TECH at $77.2 million in Q4 2025, $80.7 million in Q3 2025, and $84.0 million in Q2 2025.